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We performed a genomewide scan and genetic linkage analysis, to identify loci associated with age-relatedmacular
degeneration (AMD). We collected 70 families, ranging from small nuclear families to extended multigenerational
pedigrees and consisting of a total of 344 affected and 217 unaffected members available for genotyping. We
performed linkage analyses using parametric and allele-sharing models. We performed the analyses on the com-
plete pedigrees but also subdivided the families into nuclear pedigrees. Finally, to dissect potential genetic factors
responsible for differences in disease manifestation, we stratiﬁed the sample by two major AMD phenotypes
(neovascular AMD and geographic atrophy) and by age of affected family members at the time of our evalua-
tion. We have previously demonstrated linkage between AMD and 1q25-31 in a single large family. In the com-
bined sample, we have detected the following loci with scores exceeding a cutoff under at least oneLODp 2
of the models considered: 1q31 ( at D1S518), 3p13 ( at D3S1304/D3S4545), 4q32HLODp 2.07 HLODp 2.19
( at D4S2368, for the subset of families with predominantly dry AMD), 9q33 ( atHLODp 2.66 LOD p 2.01Zlr
D9S930/D9S934), and 10q26 ( at D10S1230). Using correlation analysis, we have found a sta-HLODp 3.06
tistically signiﬁcant correlation between LOD scores at 3p13 and 10q26, providing evidence for epistatic inter-
actions between the loci and, hence, a complex basis of AMD. Our study has identiﬁed new loci that should be
considered in future mapping and mutational analyses of AMD and has strengthened the evidence in support
of loci suggested by other studies.
Introduction
Age-relatedmacular degeneration (AMD [MIM603075])
is a leading cause of blindness in the United States and
other Western countries (Klein et al. 1992; Evans and
Wormald 1996). In recent years, evidence for a signiﬁcant
genetic component has prompted a search for genes that
may cause or increase susceptibility to AMD. Previous
studies have consisted primarily of case-control methods
(Allikmets et al. 1997) or linkage studies employing small
families (Weeks et al. 2001).
In the present article, we describe our ﬁndings from
a genomewide scan of extended families with AMD. A
large part of our data set consists of multigenerational
families. Families of this type have previously been suc-
cessfully employed in the identiﬁcation of at least one
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candidate AMD locus, 1q25-31 (Klein et al. 1998),which
was later conﬁrmed by an independent study (Weeks et
al. 2001). In contrast to other studies, which have focused
on affected sibs and relatively small nuclear families
(Weeks et al. 2000, 2001; Haines et al. 2002; Iyengar et
al. 2002), some of the families that we have studied are
large enough to individually attain, under a dominant
genetic model, maximum LOD scores exceeding the gen-
erally accepted cutoff of 3. Previous AMD studies (Weeks
et al. 2000, 2001; Haines et al. 2002; Iyengar et al. 2002)
have met with limited success, possibly because of a com-
plex genetic basis of the disease or because of a high
degree of genetic heterogeneity (i.e., a large number of
independent loci and mutations being responsible for the
observed phenotype). Because of the large size of the
families that we studied, if the genetic basis of the disease
is relatively close to dominant inheritance and only one
locus is segregating in each family, then we should be
able to detect linkage within individual families even in
the presence of genetic heterogeneity. Our combined sam-
ple should also be large enough to identify loci that con-
tribute to possible complex inheritance patterns of AMD.
In the present article, we identify several candidate loci,
some of which constitute novel ﬁndings and others of
which have been implicated in previous studies. In view
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of our results, we also discuss the possible etiology of
AMD.
Families and Methods
Families
The study population consisted of 561 members of
70 families recruited in the Paciﬁc Northwest region of
the United States. There were 344 affected and 217 un-
affected individuals. Each family had 3–14 (average 4.9)
living family members with AMD. Families were recruit-
ed initially from M.L.K.’s practice and later via adver-
tisements in various newspapers in the Northwest and
organizations serving the blind. Extensive recruitment
efforts to recruit new families included announcements
and presentations at local meetings, letters to eye-care
providers, articles in local senior-citizen newspapers, ar-
ticles in institutional news publications, and paid recruit-
ment advertisements in major newspapers throughout
the Paciﬁc Northwest. We also had good success in the
identiﬁcation of new families after we were given permis-
sion to contact members of the Oregon Commission for
the Blind. All families were of northern European de-
scent. Pedigrees had to have a minimum of three living
members who met our deﬁnition of AMD to be consid-
ered as a family. AMD was deﬁned as follows: (1) geo-
graphic atrophy or choroidal neovascularization accom-
panied by drusen in the macula (“late age-related macu-
lopathy” [ARM]) or (2) extensive large drusen 1393,744
mm2 in area (0.2 disc areas). In the Beaver Dam Eye
Study, this amount of drusen represented the highest-
risk category for the development of late ARM (55.3%
in 10 years) (Klein et al. 2002). Unaffected individuals
(Klein et al. 1998) did not have these features, and those
with no drusen 1125 mm in minimum diameter were con-
sidered as deﬁnitely unaffected. We documented affected
status of family members with retinal photography.
Genotyping
Genotyping was performed in two successive stag-
es. The initial set of 21 families with AMD, comprising
only affected individuals, was genotyped by the Na-
tional Heart, Lung, and Blood Institute (NHLBI)Mam-
malian Genotyping Service, using a full-genome set of
364 markers from Marshﬁeld screening set 9. While
the ﬁrst analysis was under way, additional families
with AMD, along with additional individuals from the
families already under investigation, were ascertained.
The total sample size was thus increased to 70 infor-
mative pedigrees, consisting of a total of 344 affected
and 217 unaffected members available for genotyping.
The second set of families, which included unaffected
individuals, was again genotyped by theMarshﬁeld Foun-
dation, but the NHLBI Mammalian Genotyping Service
this time used a newer panel of markers, screening set 10.
The data from the two genome scans were subsequently
combined and used in linkage analysis.
Linkage Analysis
Initially, we analyzed the original set of 21 families.
We checked the genotyping data for errors by using the
PedManager (available from M. P. Reeve of the Massa-
chusetts Institute of Technology [mpreeve@genome.wi
.mit.edu]) and PedCheck (O’Connell and Weeks 1998)
programs. In many cases, the error could be eliminated
by untyping a single individual in predominantly mul-
tiple-sib families. In the remaining cases, the entire nu-
clear family in which an inconsistency was found was
untyped. The Marshﬁeld genotyping software indicated
several mispaternity cases, which we then handled by
including an additional father in the pedigree ﬁles. We
analyzed the data by using the Analyze/Linkage software
package (Cottingham et al. 1993; Terwilliger and Ott
1994), for two-point analysis, and the Allegro software
(Gudbjartsson et al. 2000), for multipoint and nonpara-
metric analyses. Later, when a number of additional fam-
ilies had been collected, they were added to the sample,
yielding a total of 70 families analyzed.
The combined data included results from two separate
genotyping efforts. Several markers differed between the
two genotyping panels (screening sets 9 and 10); some
were present only in the ﬁrst scan, and others were present
only in the second scan. In the second scan, many of the
original markers were replaced by more polymorphic, or
more consistently ampliﬁed, markers at the same genetic
position. In such cases, we obtained the physical order of
the markers from the human genomic sequence assembly
at the University of California at Santa Cruz (Kent et al.
2002) and assumed an arbitrary genetic separation of
0.01 cM for multipoint linkage analysis. In addition,
within families, some individuals were often typed using
screening set 9, and others were typed using screening
set 10. In effect, to extract full information from the pedi-
grees, we relied on multipoint, rather than two-point, anal-
yses. Finally, even for markers shared between the two
scans, there remained four obvious inconsistencies in allele
sizing. We were able to correct those discrepancies by re-
calibrating allele sizes to ﬁt consistent Mendelian trans-
mission.
We performed linkage analysis under threemodels (for
summary, see table 1). Model 1 is a parametric model
with a dominant mode of inheritance, 0.01 frequency
of the disease allele, and a set of age-dependent pene-
trances determined by the frequency of AMD in various
age groups within families, as described by Klein et al.
(1998). For each age group, the phenocopy rate is 10%
of its associated penetrance. We used the following
phenocopy and penetrance values, with the three val-
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Table 1
Analysis Methods
MODEL
DIAGNOSTIC SCHEME
A. All Affected
and Unaffected
Individuals
B. All Affected and Deﬁnitely
Unaffected Individuals
C. All Affected and Deﬁnitely
Unaffected Individuals
(Nuclear Families)
1. Parametric with age-dependent penetrances 1A 1B …
2. Parametric with constant high penetrance
and low phenocopy rate 2A 2B 2C
3. Nonparametric allele sharing ( )Zlr 3A … 3C
ues given in order corresponding to noncarriers of the
disease allele, heterozygous carriers, and homozygous
carriers: (0.0001, 0.001, 0.001), (0.001, 0.01, 0.01),
(0.009, 0.09, 0.09), (0.042, 0.42, 0.42), and (0.095,
0.95, 0.95), for the respective age groups of !50, 50–
54, 55–64, 65–74, and 75 years.
Although the model described in the preceding par-
agraph (model 1) is derived in a rigorous manner, in
general, the use of genetic models that include a large
percentage of phenocopies (affected noncarriers) results
in low power to detect linkage. Hence, we also used
model 2, a parametric approach that assumes a relatively
low phenocopy rate of 0.05, as well as relatively high
penetrances of 0.95 for both hetero- and homozygous
individuals. Although the parameters of the model are
arbitrary, faced with an uncertain mode of inheritance
of AMD, we used this model in order to increase the
statistical power of the analysis. For both parametric
models, we assumed a 0.01 frequency of the disease
allele; this relatively high frequency is justiﬁed in view
of the high population prevalence of AMD. Note that,
although the use of a misspeciﬁed genetic model does
not lead to an increase in false-positive rates (Williamson
and Amos 1995), the use of multiple models will result
in an overall decreased signiﬁcance of each analysis.
In view of the uncertain mode of inheritance of the
disease, we also used model 3, a nonparametric approach
based on an allele-sharing statistic, the exponential pairs
score. Among allele-sharing approaches, the aboveZ lr
statistic has been found to perform well for a variety of
underlying disease models (McPeek 1999).
Care should be taken when comparing the results of
the parametric and nonparametric analyses. The para-
metric LOD scores allowing for genetic heterogeneity
(HLOD scores), which are reported here, require the
estimation of the heterogeneity parameter (proportion
of families segregating a given locus) and have 11 df.
Ott (1999) recommends increasing the signiﬁcance
cutoff required for LOD scores by 0.3, to account for
the additional parameter—that is, cor-HLODp 3.3
responds to the statistical signiﬁcance of .LODp 3
Thus, pointwise results of parametric (HLOD) and non-
parametric ( ) analyses are not equivalent. How-LODZlr
ever, in their classic article concerning genomewide sig-
niﬁcance levels, Lander and Kruglyak (1995) recommend
a genomewide 3.3 cutoff for parametric LOD (and, there-
fore, a 3.6 threshold for HLOD) and a 3.6 cutoff for al-
lele-sharing methods based on sib pairs. The latter thresh-
old is even higher for allele sharing between other relative
pairs. Thus, when considered in a genomewide context,
the two statistics (HLOD and ) may actually beLODZlr
comparable.
We performed the above analyses under two different
diagnostic schemes. Scheme A included the entire col-
lection of affected, unaffected, and unclassiﬁed individ-
uals. Scheme B included affected and unclassiﬁed indi-
viduals and only those unaffected individuals classiﬁed
as deﬁnitely unaffected (all other unaffected individuals
were included in the analysis but with an unknown af-
fection status).
It has been suggested elsewhere (Badner et al. 1998)
that, for the analysis of complex traits caused by com-
mon alleles, extended pedigrees may not be the optimal
units for linkage analysis and that, in some cases, the
power obtained from nuclear families may be greater
than from large pedigrees. Hence, we also used scheme
C, which followed the diagnostic criteria of scheme B
(above) but also involved subdividing the pedigrees into
nuclear families (72 informative nuclear pedigrees, with
averages of 3.1 affected and 0.5 unaffected sibs). This
approach should be more effective in the presence of
several disease loci segregating in large pedigrees and is
more similar to approaches used by other groups (Weeks
et al. 2000, 2001; Iyengar et al. 2002), in which collec-
tions of sib pairs or much smaller nuclear families are
often analyzed.
In addition, we considered the possibility that AMD
subgroups may exist that have distinct genetic inﬂuenc-
es. We therefore performed additional analyses on sam-
ples stratiﬁed according to two important criteria: (1)
advanced AMD phenotype (i.e., dry [geographic at-
rophy] vs. wet [neovascular] AMD) and (2) age at as-
certainment (i.e., early vs. late). Thus, the ﬁrst strati-
ﬁcation involved subdividing our sample into families
in which members had advanced AMD that was pre-
dominantly dry (150% of the affected individuals, with
a total of 27 families) or predominantly wet (43 fam-
ilies). The second stratiﬁcation included families com-
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Table 2
Multipoint LOD Scores Exceeding the 1.5 Cutoff in Individual Families (Model 2B)
Marker(s)
Position
(cM) Family LOD P Reference(s)
Chromosome 1:
D1S3723/D1S534 150.13 AMD199 1.58 .24
D1S1589 192.05 AMD159 2.59 !.01 Weeks et al. 2001
D1S518 202.19 AMD30 2.51 .05 Klein et al. 1998, Weeks et al. 2001
Chromosome 2:
D2S410 125.18 AMD133 2.10 .10
D2S1353 164.51 AMD159 1.52 .61
D2S2944 210.43 AMD32 2.03 .25
Chromosome 3:
D3S4545 26.25 AMD159 1.86 .23 Iyengar et al. 2002
D3S4529 112.42 AMD7 1.78 .56
D3S2460 134.64 AMD187 1.71 .07
D3S2418 215.84 AMD104 1.55 .49
Chromosome 4:
D4S1644 143.31 AMD4 2.17 .23
Chromosome 9:
D9S1122/D9S922 75.88 AMD159 1.53 .60 Weeks et al. 2000
Chromosome 10:
D10S1230 142.78 AMD104 1.55 .49 Weeks et al. 2001, Haines et al. 2002, Iyengar et al. 2002
Chromosome 12:
D12S1064 95.03 AMD7 1.90 .33 Iyengar et al. 2002
Chromosome 17:
D17S2193 89.32 AMD4 1.97 .29
Chromosome 18:
D18S844 116.44 AMD33 1.94 .21
Chromosome 19:
D19S591 9.84 AMD7 1.85 .48
NOTE.—The reported P values are empirical genomewide false-positive rates based on 100 replicates of simulated null
data.
posed of affected members with an average age of !75
years (14 families) or 75 years (56 families).
For the multipoint analyses performed using Allegro
(Gudbjartsson et al. 2000), nine of the families that we
studied exceeded the size limit of the program and had
to be trimmed. This could be done with a small loss
of power, by removing unclassiﬁed or young unaffected
individuals (who may still develop the disease at a later
age). One large family, AMD126 (56 individuals), had
to be split into two equal-size pedigrees.
Allele frequencies were estimated from the data by
using PedManager. The estimates were based on the
counting of allele frequencies in all genotyped individ-
uals. Although such an approach is not as accurate as
maximum-likelihood estimates that consider relation-
ships within pedigrees, it is favorable because of its
simplicity and is generally conservative with respect to
ﬁnal statistical signiﬁcance of linkage analysis (Weeks
et al. 2001). However, to conﬁrm that our most sig-
niﬁcant signals were not due to misspeciﬁcation of al-
lele frequencies, for each of the peaks (1q25-31, 3p13,
4q32, 9q33, and 10q26), we used the maximum-like-
lihood estimation implemented in Ilink (Terwilliger and
Ott 1994) to estimate allele frequencies for nine mark-
ers surrounding each peak. Linkage analyses were then
repeated using the maximum-likelihood frequency es-
timates. None of the results were signiﬁcantly altered;
all LOD scores obtained with maximum-likelihood es-
timates were within 2% of the original values.
We used simulations to determine the empirical sig-
niﬁcance levels of our results. Unfortunately, because
of constraints on computational time, we could analyze
simulated data only for individual families (table 2),
rather than for the entire data set. For each family, we
used Allegro to simulate 100 replicates of null data of
the entire genome scan. Genotypes were simulated in
accordance with the original pedigree structures and
only for the individuals who were available for geno-
typing in our data set. Allele frequencies for the sim-
ulation were obtained from the real data set. Geno-
typing efﬁciency (i.e., the fraction of genotypes that
were unambiguously determined) was set to 85%, to
account for missing and inconsistent genotypes, as well
as differences in markers used in the two genotyping
panels. This means that 15% of genotypes were random-
ly assigned an “unknown” value. The resulting P values
represent genomewide signiﬁcance levels (i.e., the frac-
tion of replicates that contained LOD scores at least as
extreme as those observed). The relatively low number
of replicates was limited by constraints on computation-
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Table 3
Pearson Correlation Values (r) and Associated P
Values between Candidate Loci
1q25-31 3p13 9q33 10q26
1q25-31 … .02 .85 .15
3p13 .2805 … .52 .002a
9q33 .0235 .0794 … .03
10q26 .1743 .3666 .2523 …
NOTE.—Correlation values are given in the lower
left of the matrix, and associated P values are given
in the upper right of the matrix.
a Signiﬁcant at the Bonferroni-corrected P ! .05
level.
al time. The results should be viewed with some caution
but should provide a useful indication as to which fam-
ilies provide particularly strong evidence of linkage.
Correlation Analysis
To investigate the evidence for interactions between
our candidate loci, we constructed a pairwise Pearson
correlation matrix for family-speciﬁc LOD scores at the
four candidate regions that were detected using our un-
stratiﬁed sample (table 3). For each of the 70 families,
individual LOD scores at the location of each peak were
calculated under the corresponding genetic model that
was initially used to detect the peak (dominant with no
age dependence for 1q25-31, 3p13, and 10q26; allele
sharing for 9q33). The P values associated with the cor-
relation coefﬁcients were corrected for multiple testing
by dividing by the total number of comparisons (Bon-
ferroni correction). We used two methods to correct for
departures from normal distribution of the data: (1) out-
lier correction (removing families with extreme values
that have a large effect on the signiﬁcance of analysis),
performed using the Hadi outlier method implemented
in Systat 8.0 software (SPSS); and (2) the nonparametric
Kendall’s t correlation test.
To further exclude the possibility that the observed cor-
relation between LOD scores may be caused by variation
in family sizes and, hence, variation in information con-
tent across families, we performed the following partial
correlation analysis: (1) we determined themaximumpos-
sible LOD score ( ) for each family in the data set,LODmax
by calculating the LOD score between the disease marker
and itself (the values represent a measure of in-LODmax
formation content); (2) we log-transformed val-LODmax
ues to ensure a better approximation to a normal distri-
bution; and (3) we used the transformed valueLODmax
as a conditional variable, to compute the partial corre-
lation between LOD scores observed at candidate loci.
This analysis corrects the correlation for the effect of var-
iation in family size.
Results
Linkage Analysis
Our initial analysis of 21 families uncovered a single
region with LOD scores suggestive of genetic linkage.
We found a LOD score of 2.07, based on the allele-
sharing exponential pairs statistic, on chromosomeZ lr
9, between D9S930 and D9S934. After genotyping six
additional markers between D9S938 and D9S1825, we
found no change in the LOD scores and no change in
the location of the peak. There were no other peaks
exceeding a LOD-score cutoff of 1.5 in the initial ge-
nome scan.
Subsequently, we included additional families and in-
dividuals to increase the sample size, and we performed
analyses of combined data by using different geneticmod-
els and diagnostic schemes (see table 1 and the “Families
andMethods” section). The results are shown graphically
in ﬁgure 1. Below, we describe regions with scores exceed-
ing the threshold under at least one analysisLODp 1.5
method. Incidentally, all of the loci reported below also
exceed the cutoff when we include results fromLODp 2
the groups stratiﬁed by predominant phenotype and by
age of affected members at ascertainment. A threshold of
is often used as a criterion for suggestive link-LODp 2
age. However, note that, because multiple analyses have
been performed, the actual statistical signiﬁcance level is
lower than it would be for a single test.
The highest overall peak, with an HLOD score of
3.06, was found on chromosome 10, at D10S1230 (ge-
netic location 143 cM), using genetic model 2 and break-
ing down the pedigrees into nuclear families (see scheme
C, in table 1 and the “Families and Methods” section).
This locus has been reported previously (Weeks et al.
2001).
The second-highest peak, , was found onLODp 2.01
chromosome 9, at D9S934 (136 cM), 4 cM telomeric
of the peak location on chromosome 9 in the initial 21
families. This result was obtained using the allele-sharing
approach in entire pedigrees (model 3A). Note that para-
metric analysis of the entire data set under the age-de-
pendent–penetrance model (model 1A) yielded an HLOD
score of 1.48 at the same location. This appears to be
a novel locus, not seen in any previous studies to our
knowledge.
The third peak is an HLOD score of 1.81 on chromo-
some 3, between D3S1304 and D3S4545 (27 cM). This
result was obtained using the parametric model with age-
independent penetrance (model 2B). This locus has been
observed in a previous study (Iyengar et al. 2002).
Our ﬁnal peak in the unstratiﬁed data set, with a max-
imum HLOD score of 1.70 at D1S518 under parametric
model 2B, corresponds to the 1q25-31 locus reported
earlier by Klein et al. (1998) and Weeks et al. (2001).
To dissect potential genetic factors responsible for dif-
Majewski et al.: Genomewide Linkage Scan for AMD 545
ferences in disease manifestation, we then stratiﬁed the
sample by the two major phenotypes of advanced AMD
(predominantly wet [neovascular AMD] and predomi-
nantly dry [geographic atrophy]) and by age of affected
family members at the time of our evaluation. The most
notable result of this analysis was an HLOD score of
2.66 at D4S2368 (on chromosome 4, at 168 cM) for
the predominantly-dry-AMD subgroup undermodel 1A.
This peak represents another novel locus, not implicated
in any earlier studies to our knowledge.
Within the age-stratiﬁed sample, we found that our
peak on 3p13 increased to HLOD p 2.19 (model 2A)
for the sample of families with early age at ascertain-
ment. We also found an HLOD score of 1.57 (model
2B) and of 2.07 at 1q25-31 (marker D1S518).LODZlr
We also report regions with LOD scores exceeding
1.5 in individual families. Since the age-dependent–
penetrance model generally produces very low individ-
ual scores, we report scores by using the constant-pen-
etrance LOD-score analysis of entire families (model
2A). The results are shown in table 2. Note that several
of the loci map to regions that have been suggested by
other studies (Klein et al. 1998; Weeks et al. 2000,
2001; Iyengar et al. 2002).
Correlation Analysis
For the four candidate regions (1q25-31, 3p13, 9q33,
and 10q26) that were detected within the unstratiﬁed
data set, we performed a correlation analysis (similar to
that performed by Cox et al. (1999) on non–insulin-de-
pendent diabetes mellitus data) to detect correlations be-
tween LOD scores at the peak locations within individ-
ual families. The results are shown in table 3. Our data
provide evidence for a statistically signiﬁcant interaction
between 10q26 and 3p13 ( ; ). Afterrp 0.367 Pp .002
correction for multiple testing (Bonferroni correction),
the correlations between the remaining pairs of loci were
not statistically signiﬁcant, but the Bartlett test for2x
sphericity of the determinant, which detects the presence
of correlations within the entire table, was highly signifi-
cant ( ; ; ), indicating that2x p 19.989 dfp 6 Pp .003
more than one interaction may be present. Since both
the Bartlett test and the Pearson correlation analysis2x
are sensitive to deviations of the data from normality,
we performed two additional tests—Pearson correlation
with outlier correction and the nonparametric Kendall’s
t correlation (see the “Families and Methods” section).
The correlation is robust with respect to the outlier cor-
rection ( ; ) and remains signiﬁcantrp 0.373 Pp .001
under the nonparametric Kendall’s t correlation test
( ; ). Finally, to exclude the possibilityrp 0.22 Pp .008
that the observed correlation may be caused by variation
of information content across families of different sizes,
we performed partial Pearson correlation analysis, cor-
recting for the effect of family size (see the “Families
and Methods” section). Again, the partial coefﬁcient
of correlation between 10q26 and 3p13 is signiﬁcant
( ; ). All of the above tests of the cor-rp 0.334 Pp .005
relation between 10q26 and 3p13 are signiﬁcant after
correction for multiple testing within the corre-4# 4
lation matrix.
Discussion
AMD is the leading cause of vision loss in elderly Amer-
icans. As such, it has recently acquired close attention
from geneticists. Previously, our group conducted link-
age analysis in a large family (AMD30) and identiﬁed
a candidate locus on 1q25-31. The segregation of the
disease within family AMD30 was largely in agreement
with a dominant Mendelian mode of inheritance. Since
then, one group has published the results of their ge-
nomewide scan (Weeks et al. 2000, 2001), and another
group has reported preliminary data on large collections
of affected families (Iyengar et al. 2002). Neither groups’
results indicated the presence of a single, major AMD
locus, and, with one exception (Weeks et al. 2001), sug-
gestive peaks were generally low ( ). Thus, it isLOD ! 3
likely that, whereas AMD is caused by a major effect of
a single gene in some pedigrees (e.g., AMD30), the dis-
ease may have more complex underlying genetic mech-
anisms in other pedigrees. There may be a high level of
genetic locus heterogeneity, resulting in different loci seg-
regating with the disease in various families. Moreover,
there may exist complex epistatic interactions between
the loci, with interactions between different sets of loci
resulting in similar phenotypes, even in related individ-
uals.
Despite the availability of large sample sizes, LOD
scores obtained by various groups failed to provide clear
evidence of linkage at the commonly accepted statistical
signiﬁcance levels, particularly after accounting for the
multiple diagnosis and analysis methods commonly em-
ployed in each study. In view of the above problems,
emphasis must be placed on cross-validation of results
obtained by different groups, even without individually
achieving statistical signiﬁcance, as a method to narrow
the regions of interest. In addition, we ﬁnd that the
uncertain mode of inheritance of AMD justiﬁes and ne-
cessitates the use of several analysis methods. Although
the use of multiple models decreases the actual signiﬁ-
cance levels (and hence increases false-positive rates) of
the results, it remains a valid approach to the identiﬁ-
cation of the most likely candidate regions. Our present
analysis provides evidence in support of candidate loci
suggested by earlier studies, as well as evidence of new
candidates that should be taken into consideration in
future linkage analyses.
First, let us consider the 1q25-31 locus, which we
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Figure 1 Genomewide linkage results of the three most signiﬁcant analyses (models 1A, 2B, and 3A [for summary, see table 1]). Chro-
mosomes 4 and 10 data include additional analyses (under models 2B-dry and 2C, respectively) that have produced notable results. The candidate
regions, on chromosomes 4 and 9, constitute novel loci and have not been reported in previous studies. The remaining regions, on chromosomes
1, 3, and 10, have been also reported by previous and ongoing studies. The genetic locations correspond to the Marshﬁeld genetic map (Broman
et al. 1998) and are expressed in Kosambi cM. Note that the HLOD and curves represent statistics with different numbers of degreesLODZlr
of freedom (for a brief discussion regarding the comparison of the two statistics, see the “Families and Methods” section).
previously identiﬁed with a LOD score of 3 in one large
family, AMD30, and which Weeks et al. (2001) con-
ﬁrmed with anHLOD score 12. In our extended sample,
we see a maximum-HLOD-score peak of 1.70 under
genetic model 2B. We ﬁnd one additional large family,
AMD159, consisting of 25 individuals (14 of whom
were genotyped) and including 6 affected and 5 deﬁ-
nitely unaffected individuals, that shows evidence of
linkage at this locus ( , under model 2B).LODp 2.59
All of the haplotypes within this family were consistent
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with linkage, providing further evidence for the exis-
tence of an AMD gene on 1q25-31.
The analysis performed by Weeks et al. (2001), how-
ever, has suggested that the percentage of families with
AMD that are segregating a gene at 1q25-31 is very
high, 140%. In our sample, depending on the model
used, the maximum-likelihood estimate for the propor-
tion of linked families varies between 0.07 and 0.15.
Hence, although our data provide additional support
for linkage to 1q25-31, we believe that the proportion
of AMD cases that can be explained by this locus is
considerably lower than had been previously suggested
and is probably !15%. Note that the difference between
the two studies may be partially due to the larger size
of the families that we studied and that the interpre-
tation of estimates of proportions of linked families may
be problematic and should generally be treated with
caution (Whittemore and Halpern 2001).
548 Am. J. Hum. Genet. 73:540–550, 2003
The locus on 10q26 ( , under mod-HLODp 3.06
el 2C) is our most signiﬁcant candidate. It has also
been implicated in at least two other independent
AMD linkage studies. Weeks et al. (2000, 2001) found
a maximum nonparametric linkage (NPL) score of
1.42 in their initial study and an LOD score of 2.02Sall
in their expanded sample, at D10S1230. Iyengar et al.
(2002) used allele-sharing methods to obtain a P value
of .023 at D10S212 (20 cM telomeric of D1S1230).
Haines et al. (2002) found a maximum LOD score
(MLS) of 1.12 at D10S1230, the highest peak of the
four candidate regions that they investigated.
The detection of this locus in all of the studies per-
formed to date suggests that 10q26 may contain a com-
mon AMD gene, either a causative (major effect) gene
or a modiﬁer (a gene that controls the effects of the
major locus, e.g., mode of inheritance, penetrance, and
age at onset). Interestingly, a modiﬁer gene for the age
at onset of two neurodegenerative disorders, Alzheimer
disease and Parkinson disease, has recently been sug-
gested to reside on 10q (Li et al. 2002) and may cor-
respond to the same locus. Furthermore, we propose
that the locus at 10q26 may act through a frequent
allele. Our data support this hypothesis, since the anal-
ysis becomes signiﬁcant only after subdivision of our
extended pedigrees (maximum ) into nu-HLODp 1.10
clear families ( ). If an allele is common,HLODp 3.06
it may enter extended pedigrees through multiple mar-
ried-in individuals, rendering parametric linkage anal-
ysis ineffective (Badner et al. 1998). However, subdi-
vision of the families ensures that, within each nuclear
family, the disease allele may enter the pedigree only
through the parents, rendering multiple origins less
likely and linkage analysis more effective.
The peak on 9q33 is our most robust peak with re-
spect to the analysis method. It was observed in our
initial sample, in the expanded sample, and in both
parametric and nonparametric analyses, as well as after
subdivision of the pedigrees into nuclear families. Al-
though Weeks et al. (2000) mention a possible AMD
locus at D9S1838, we believe our 9q33 locus to be
novel, because our peak at D9S934 is ∼38 cM proximal
to their peak at D9S1838; furthermore, although our
LOD score at 9q33 remained relatively unchangedwhen
additional families were genotyped, their LOD score at
the D9S1838 locus decreased signiﬁcantly on doubling
the number of sib pairs analyzed and was no longer
mentioned as a possible AMD locus (Weeks et al. 2001).
We suggest that 9q33 should be considered as a can-
didate locus in future screening studies.
Our peak on 3p13 has been described in the study
by Iyengar et al. (2002) ( ). This peak occursPp .012
only in one type of analysis in the present study—
namely parametric model 2B without age-dependent
penetrance, with only deﬁnitely unaffected individ-
uals included. Once again, we varied the model pa-
rameters and sample content to ﬁnd the conditions
under which this peak is maximized. We found the
most signiﬁcant factor to be the type of families in-
cluded in the sample. When we limited the sample to
pedigrees in which the affected individuals had pre-
dominantly (150%) dry AMD, the HLOD score at
3p13 increased to 2.19.
Within the combined collection of families in the
present study, we found no evidence supporting link-
age to two other loci indicated in other studies, namely
9p13 and 17q25 (Weeks et al. 2000, 2001). We found
slight evidence supporting another candidate locus,
12q22 (Weeks et al. 2000; Iyengar et al. 2002). Our
most signiﬁcant peak close to this locus was a -basedZ lr
LOD score of 0.96 between the markers PAH and
D12S2070 (at 113.5 cM).
We also investigated maximum-LOD-score signals
within individual families. This approach should be
effective in view of the apparent genetic heterogenei-
ty of AMD. However, with the exception of families
AMD30 and AMD159, we found that most families
failed to reach their maximum possible LOD scores (in
which case all haplotypes would be consistent with link-
age and there would be no recombination between the
candidate region and the disease locus). We ﬁnd two
possible explanations: First, although most investiga-
tors consider neovascular and atrophic forms of AMD
as different manifestations of the same disorder, muta-
tion of some genes may predispose the individual to a
disease dominated by only one of the two phenotypes;
thus, the deﬁnition of AMD used in the present study
may encompass different underlying genetic mecha-
nisms. The second explanation invokes both the high
genetic heterogeneity of the disease—multiple disease
loci segregating even within individual families—as
well as complex epistatic interactions between loci.
Note that several of the peaks observed in individu-
al families correspond to loci indicated by prior stud-
ies—speciﬁcally, D3S4545, on 3p (Iyengar et al. 2002);
D9S1122/D9S922, on chromosome 9 (close to the mi-
nor peak observed by Weeks et al. [2001]); D10S1230,
on chromosome 10 (Weeks et al. 2000, 2001; Haines
et al. 2002; Iyengar et al. 2002); and D12S1064, on
chromosome 12 (within 10 cM of the most signiﬁcant
peak observed by Iyengar et al. [2002]). The remaining
loci in table 2 have not been observed before. All the
candidate loci will be ﬁne-mapped and screened for
candidate genes in the later stages of this project.
In the analysis of individual families, we ﬁnd that
several families have peaks exceeding atLODp 1.5
several different loci—including families AMD4 (chro-
mosomes 4 and 17), AMD7 (chromosomes 3, 12, and
19), AMD104 (chromosomes 3 and 10), and AMD159
(chromosomes 1, 2, 3, and 9)—lending additional sup-
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port to the hypothesis of cosegregation of distinct loci
and, hence, to a complex basis of the disease. To test
the above hypothesis, we performed a correlation anal-
ysis between family-speciﬁc LOD scores at the four loci
observed in our unstratiﬁed sample: 1q25-31, 3p13,
9q33, and 10q26. We found a strong indication of an
overall presence of interactions ( ). The effectPp .003
was mostly due to a correlation between 3p13 and
10q26 ( ). A positive correlation coefﬁcientPp .002
may be interpreted as evidence of an epistatic interac-
tion, whereas a negative correlation may also represent
genetic heterogeneity (Cox et al. 1999; Majewski et
al. 2001). The 3p13-by-10q26 interaction is associated
with a positive correlation coefﬁcient, supporting both
the hypothesis that AMD is a complex genetic disorder
and our suggestion that 10q26 may harbor a common
modiﬁer locus (see above).
In conclusion, we have found evidence of new loci
contributing to AMD, at 4q32 and 9q33. These loci
will be studied in future mapping and mutational anal-
yses. We also found additional evidence supporting loci
indicated by other studies—in particular, 1q31, 10q26,
and 3p13—and indication of epistatic interactions be-
tween candidate loci. The discovery of the genes at these
loci and the study of the products encoded will be im-
portant future steps in the unraveling of the processes
that result in the common phenotypes of AMD. In view
of the complex nature of the genetics of AMD, we be-
lieve that all of these loci have the potential to harbor
genes that cause AMD, either alone or in combination,
or genes that act as modiﬁers to the age at onset, degree
of severity, or eventual phenotype. Many of the gene
products may be found to interact in common, if not
novel, cellular functions and biochemical pathways that
have yet to be discovered. The understanding of the
molecular biology and biochemistry that underlie AMD
will allow the creation of molecularly based pharma-
ceuticals and will help in the identiﬁcation of new ther-
apeutic interventions to prevent or slow the course of
these blinding disorders.
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